Match Document Document Title
US20140099363 CAPSULES COMPRISING AN EMULSIFIED SYRUP AND METHODS OF MAKING THE SAME  
This invention provides capsules and, more specifically soft capsules, wherein the fill material comprises an emulsified syrup. In particular, the present invention provides a means of...
US20120121670 POLYARGININE NANOCAPSULES  
The present invention relates to a system for administering active ingredients comprising nanocapsules with a diameter less than 1 μm comprising a polyarginine salt, a negative phospholipid and an...
US20110027355 HIGH-FLUIDITY AND NON-CAKING PULVERULENT CRYSTALLINE MALTITOL COMPOSITION  
A pulverulent crystalline maltitol composition, is characterized in that it has a laser volume mean diameter between 10 and 150 μm; in that it has a maltitol content between 80 and 99.9% by...
US20110217368 BACTERIAL COMPOSITIONS FOR PROPHYLAXIS AND TREATMENT OF DEGENERATIVE DISEASE  
The disclosure provides an oral composition for reducing serum cholesterol, serum lipids, body fat, or atherogenic index or for prophylaxis or treatment of atherosclerosis, cardiovascular or...
US20100330168 PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE AND USES THEREOF  
Novel pharmaceutical compositions contain micronized progesterone and at least one oleic safflower oil referred to as safflower oil type II, and medicines comprising said compositions are useful...
US20060029659 Immune dengue plus  
An immune enhancing blood platelet builder that increases the survival rate of the patient against the duration of the dengue fever virus in the body.
US20140170213 CAPSULE FORMULATION COMPRISING MONTELUKAST AND LEVOCETIRIZINE  
Disclosed is a capsule formulation for preventing or treating allergic rhinitis and asthma, which comprises two separate layers of: (1) a Montelukast layer comprising montelukast or a...
US20110014250 INHIBITORS OF 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE FOR STIMULATING PIGMENTATION OF THE SKIN OR SKIN APPENDAGES  
Inhibitors of 15-hydroxyprostaglandin dehydrogenase (15-PGDH), for example tetrazole, styrylpyrazole, phenylfuran, phenylthiophene, phenylpyrrazole, pyrazolecarboxamide, 2-thioacetamide and azo...
US20110081410 THERAPEUTIC AGENT FOR LOCAL INFLAMMATION  
The agents of the present invention comprise, as a main ingredient, a polyvalent metal inorganic-salt nanocapsule which encapsulates a retinoid such as retinoic acid. The agents could penetrate...
US20120269889 NON-GELATIN SOFT CAPSULE SYSTEM  
A non-gelatin encapsulation system for liquid filled soft capsules, by nature of the carrier, the cationic-ionic balance of the carrier and the active ingredients, or the concentration of the...
US20050214361 Photostabilized soft capsule  
An object of the present invention is to provide a small-sized light-stabilized soft capsule formulation, which has a shell that ensures effective light-shielding of an active ingredient...
US20130259933 CAPSULE WHICH DISINTEGRATES SPECIFICALLY IN THE LARGE INTESTINE  
The present invention is to obtain capsules which do not disintegrate in stomach and intestine after orally administrating them and which disintegrate specifically in large intestine. The present...
US20120207823 PHARMACEUTICAL PELLETS COMPRISING MODIFIED STARCH AND THERAPEUTIC APPLICATIONS THEREFOR  
Vaginal use compositions comprising pellets prepared from a debranched starch. Pellets may be conveniently prepared via extrusion/spheronization.
US20090186080 METHODOLOGY AND APPARATUS FOR ORAL DUAL DELIVERY OF HOMEOPATHIC PRODUCTS AND NON-HOMEOPATHIC PRODUCTS  
One possible embodiment of the invention may be an oral dosage apparatus comprising of a sealed, digestible container having an exterior that defines and seals a respective interior; the interior...
US20150224164 TREATMENT OF AUTISM SPECTRUM DISORDERS USING GLYCYL-L-2-METHYLPROLYL-L-GLUMATIC ACID  
This invention provides compounds, compositions and methods for treating Autism Spectrum Disorders (ASD) using glycyl-2-methylprolyl-glutamic acid (G-2-MePE) and analogs thereof. Autism Spectrum...
US20150197543 Treatment of Autism Spectrum Disorders Using Glycyl-L-2-Methylprolyl-L-Glutamic Acid  
This invention provides compounds, compositions and methods for treating Autism Spectrum Disorders (ASD) using glycyl-2-methylprolyl-glutamic acid (G-2-MePE) and analogs thereof. Autism Spectrum...
US20140170212 STABLE DIGESTIVE ENZYME COMPOSITIONS  
Compositions of the present invention, comprising at least one digestive enzyme (e.g., pancrelipase) are useful for treating or preventing disorders associated with digestive enzyme deficiencies....
US20110123605 STABLE DIGESTIVE ENZYME COMPOSITIONS  
Compositions of the present invention, comprising at least one digestive enzyme (e.g., pancrelipase) are useful for treating or preventing disorders associated with digestive enzyme deficiencies....
US20130189354 Novel Pharmaceutical Compositions for Treating Chronic Pain and Pain Associated with Neuropathy  
The present invention relates to compositions and methods for treating pain wherein the compositions comprise a combination of tramadol or a pharmaceutically acceptable salt thereof, magnesium or...
US20050136105 Consumer customized dosage forms  
Customizable dosage forms are provided. The flavor, color, sweetness, or texture of the dosage forms may be customized directly by the consumer.
US20060099246 Non-gelatin soft capsule system  
A non-gelatin encapsulation system for liquid filled soft capsules, by nature of the carrier, the cationic-ionic balance of the carrier and the active ingredients, or the concentration of the...
US20050180962 Inactivated probiotic bacteria and methods of use thereof  
The present invention provides formulations comprising inactivated probiotic bacteria, and treatment methods using the formulations.
US20150147276 NANOTHERAPEUTICS FOR DRUG TARGETING  
The invention provides compositions and methods for targeted controlled drug release. The compositions and methods can be used for treating or imaging vascular stenosis, stenotic lesions, occluded...
US20150231266 Neurotherapeutic Nanoparticle Compositions and Devices  
There are provided compositions and methods for treatment of neurodegeneative diseases and CNS injury. The compositions a pharmaceutically acceptable carrier solution; and a plurality of...
US20110086092 PHARMACUETICAL TABLETS CONTAINING A PLURALITY OF ACTIVE INGREDIENTS  
Described are stable compressed pharmaceutical dosage forms, such as tablets, layered so that incompatible active ingredients can be included in a single dosage form, and such that carry-over and...
US20120179090 TRANSMUCOSAL DELIVERY OF THERAPEUTIC AGENTS AND METHODS OF USE THEREOF  
Described herein is a transmucosal delivery device and their use for delivering bioactive agents across a mucosal membrane. The delivery devices contain a pharmaceutically acceptable oxidizing and...
US20140308343 METHOD FOR PREPARING NANOPARTICLES BASED ON FUNCTIONAL AMPHIPHILIC MOLECULES OR MACROMOLECULES, AND THE USE THEREOF  
The invention relates to a method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, optionally in the presence of at least one colipide, enabling the...
US20050202079 Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation  
The present invention relates to a novel orally administrable formulation of nitrofurantoin comprising a first component being a controlled release form, which comprises nitrofurantoin...
US20120027850 Compositions and Methods for Treatment of Aortic Fibrosis  
The invention relates to compositions comprising vasoactive intestinal peptide (VIP) or fragments thereof, and the use of such compositions in the treatment of aortic fibrosis and other associated...
US20060222699 FLAVORED VEGETARIAN CELLULOSE CAPSULE AND METHODS FOR PRODUCING SAID CAPSULE.  
A flavored vegetable starch capsule and the method of manufacture of the flavored capsule is provided. The capsule may comprise (a) from about 95% to about 100% parts by weight of cellulose, such...
US20050142186 Capsule comprising low-substituted cellulose ether and method for preparing the same  
A capsule with good disintegration properties that can quickly display its content's efficacy as well as a method for preparing the same are provided. More specifically, provided is a capsule...
US20140377342 WAFER AND CAPSULE FORMULATIONS WITH ENHANCED DISSOLUTION RATES FOR FENOFIBRATE  
The objective of this invention is to develop a novel wafer and capsule formulations using fenofibrate which is difficult to dissolve and control its release rate in vitro.
US20140287033 LIPID THERAPY  
A method including introducing into a blood stream a delipidated high density lipoprotein (HDL) and a bioactive agent. A composition including a delipidated high density lipoprotein (HDL) and an...
US20110091533 Amphiphilic polymer capsules and related methods of interfacial assembly  
Polymer capsules from amphiphilic graft copolymers comprising reactive, hydrophobic polyolefin backbones, and hydrophilic poly(ethylene glycol) (PEG) grafts are produced by self-assembly of the...
US20150017231 POLYAMINE TRANSPORT SELECTIVE THERAPEUTIC AGENTS WITH ENHANCED STABILITY  
Disclosed herein are di-substituted aryl polyamine compounds and methods of making and using the same. The di-substituted polyamine compounds act as PTS targeting agents, which selectively target...
US20110097394 TYPE A GELATIN CAPSULE CONTAINING PUFA IN FREE ACID FORM  
A pharmaceutical formulation comprising at least one omega-3 polyunsaturated fatty acid in free acid form or a pharmacologically acceptable derivative thereof is contained in a soft gelatin...
US20120288562 Acid Resistant Capsules  
The present invention relates to new acid resistant hard pharmaceutical capsules, a process for their manufacture and use of such capsules particularly but not exclusively for oral administration...
US20110244031 POROUS TABLETS AS CARRIERS FOR LIQUID FORMULATIONS  
A tablet composition, which in an easy, flexible and reproducible manner can be loaded with a relatively high amount of a pharmaceutically acceptable oily substance, may be produced in large-scale...
US20080095837 HUMAN GROWTH HORMONE FORMULATIONS  
The present invention relates to dosage forms of human growth hormone, the use of an absorption enhancer to allow absorption of human growth hormone into the systemic circulation in a biologically...
US20120003306 Pharmaceutical composition of nanoparticles for protein drug delivery  
The invention discloses a pharmaceutical composition of bioactive nanoparticles composed of chitosan, poly-glutamic acid, and a bioactive agent for oral delivery. The chitosan-based nanoparticles...
US20120039806 Compounds and Methods for Modulating an Immune Response  
The present invention relates to the identification of proteins which bind the dendritic cell marker known as Clec9A. The present invention provides new compounds for targeting therapeutic agents...
US20130019348 PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO  
This document discloses molecules having the following formula (“Formula One”) The molecules disclosed in this document are related to the field of processes to produce molecules that are useful...
US20140086986 CAPSICUM VARIETY EXHIBITING A HYPER-ACCUMULATION OF ZEAXANTHIN AND PRODUCTS DERIVED THEREFROM  
The present invention is concerned with Capsicum plants producing greater than about 0.4% zeaxanthin, by weight in the dried, ripe fruit pod flesh, which plants have been developed from...
US20140193489 Dopamine Nanocapsules and Uses Thereof  
The present invention provides a sonochemical irradiation-based method for the preparation of polydopamine (PDA) nanocapsules having reduced wall thickness and uniform size distribution, which may...
US20110171294 Enzyme composition and application thereof in the treatment of pancreatic insufficiency  
The present invention relates to a composition of at least one protease and a mode of application for treating patients suffering from pancreatic enzyme insufficiency, pancreatitis or cystic...
US20150125520 LIPID NANOCAPSULES COMPRISING A RETINOID, NANODISPERSION AND COMPOSITION CONTAINING THE SAME, PROCESS FOR PREPARING THE SAME AND USE THEREOF IN DERMATOLOGY  
Lipid nanocapsules are described that include at least one irritating active ingredient, and more specifically a retinoid in solubilized form. Also described, are nanodispersions and...
US20080038332 Stable pharmaceutical formulation comprising atorvastatin calcium  
The invention relates to a stable pharmaceutical formulation comprising an intimate admixture or admixture of crystalline or amorphous atorvastatin calcium, and a stabilizing-effective amount of a...
US20120315328 CAPSULE OF COMPOUND DANSHEN DRIPPING PILLS  
A capsule of compound danshen dripping pills are disclosed. The color of the capsule's shell is orange, yellow, green or blue and all of these colors are in the wavelength range of 446-620 nm.
US20060280777 Encapsulated energy gel compositions  
Encapsulated energy gel compositions are provided. The compositions include an energy gel center contained within an edible coating.
US20110027352 COMPOUNDS FOR USE IN THE TREATMENT OF NEUROPATHIC PAIN  
The present invention relates to the use of a beta-adrenergic receptor agonist as active ingredient for the production of a medicament for use in the treatment of neuropathic pain, in particular...